ELIQUENT

ELIQUENT Life Sciences

ELIQUENT Life Sciences offers comprehensive regulatory, quality, and safety solutions for pharmaceutical, biotech, and medical device companies. They specialize in navigating complex regulatory landscapes, including QMSR transitions and CMC solutions.

ELIQUENT Life Sciences is a premier global consulting group providing integrated regulatory affairs, pharmacovigilance, quality, and compliance solutions. They support pharmaceutical, biotechnology, medical device, and combination product companies across various therapeutic modalities and global markets. With a team of former regulators and industry leaders, ELIQUENT offers unparalleled expertise in guiding clients through the entire product lifecycle, from early development to post-approval support. Their services are designed to bring clarity to regulatory complexity, ensuring clients gain and maintain market authorization. ELIQUENT is particularly adept at assisting companies with critical transitions, such as the FDA's shift from QSR to QMSR for medical device manufacturers. They provide tailored solutions, expert commentary, and resources to ensure a smooth and successful adaptation to new regulatory frameworks. Their CMC solutions and remediation services further support companies in achieving and maintaining compliance. Their foundation is built on experts with extensive strategic and technical skills, offering objective and reliable guidance. ELIQUENT's global presence and network of experts enable them to solve complex technical challenges on a global scale, making them a trusted partner for life science innovators.

About

**Who they are**
ELIQUENT Life Sciences is a regulatory, quality, and safety solutions provider for pharmaceutical, biotech, and medical device companies. They focus on navigating complex regulatory environments.

**Expertise & scope**
* Specializes in the FDA's transition from the Quality System Regulation (QSR) to the new Quality Management System Regulation (QMSR), impacting medical device, in-vitro diagnostic, and combination product industries.
* Offers tailored solutions for adapting to the QMSR framework, which harmonizes with international QMS standards and emphasizes a data-driven, risk-based approach.
* Provides QMSR resources and consultancy, including information sheets and thought leadership content.
* Expertise extends to CMC solutions, regulatory affairs, quality and compliance, pharmacovigilance, risk management, talent solutions, remediation, and GxP consulting.

**Reputation / proof points**
* Focuses on addressing the entire product lifecycle.

Additional information

ELIQUENT positions itself as a critical partner for organizations facing the FDA's QMSR transition. They emphasize their assembly of regulatory leaders, industry experts, and technical specialists to ensure a smooth adaptation to the new framework. Their QMSR Resource Hub offers expert-driven content to help companies understand and stay ahead of evolving regulatory requirements. They also offer specialized webinars, such as a complimentary Spanish-language session on QMSR, featuring insights from their experts on navigating upcoming changes.

Key Highlights

  • Specializes in the FDA's transition from QSR to QMSR for medical device, in-vitro diagnostic, and combination product industries. Source
    “The FDA’s transition from the Quality System Regulation (QSR) to the new Quality Management System Regulation (QMSR) marks a pivotal shift for the medical device, in-vitro diagnostic, and combination product industry.”
  • Offers tailored solutions to ensure smooth and successful adaptation to the new QMSR framework. Source
    “ELIQUENT Life Sciences is uniquely positioned to support organizations during this critical transformation.”
  • Provides a QMSR Resource Hub with expert-driven content to understand new regulatory requirements. Source
    “Our QMSR Resource Hub provides expert-driven content designed to help you understand and stay ahead of new and updated regulatory requirements.”

Certifications & Trust Signals

  • Composed of regulatory leaders, industry experts, and technical specialists. Source
    “Our unprecedented assembly of regulatory leaders, industry experts, and technical specialists collaborate seamlessly”

Buyer Snapshot

Best for
  • Medical device, in-vitro diagnostic, and combination product manufacturers navigating QMSR transition
  • Companies seeking comprehensive regulatory, quality, and safety solutions
How engagement typically works
  • Collaborative, tailored solutions
  • Expert-driven content and resources
Typical deliverables
  • QMSR transition support and consultancy
  • Regulatory affairs guidance
  • CMC solutions
  • Quality and compliance strategies
  • GxP consulting
Good to know
  • Best when organizations require specialized expertise in FDA regulatory transitions and quality management systems.
HQ: United States, US
Languages: English
Timezones: EST, PST
Claim status: Listed

Services & Capabilities

FDA QMSR Transition & Inspection Readiness (ISO 13485 Alignment)

Jurisdictions: US
Countries: US
Industries: Medical Devices, IVD
Onboarding time: 7–21 days
Pricing model: Custom pricing
Service Types: QMSR/ISO 13485 Gap Assessment, SOP / Documentation Remediation, CAPA & Nonconformance Remediation
Earliest Start: flexible
Delivery Mode: Hybrid
Inspection Experience: Former FDA investigator on team, Supports mock inspections regularly, ISO 13485 lead auditor capability

Additional fda_qmsr_transition_inspection_readiness Details

Service Types
QMSR/ISO 13485 Gap Assessment, SOP/Documentation Remediation, Training & Competency Programs, 483 Response & Remediation Support
Earliest Start
flexible
Delivery Mode
Hybrid
Inspection Experience
Supports mock inspections regularly
Request quotes
Cruxi - Regulatory Compliance Services